September 10 & 11, 2012 | Boston, Massachusetts
Diabetes and the Heart 2012 is the fourth annual summit of the Joslin Diabetes Center and Cleveland Clinic partnership. Among the largest and most respected Academic providers of CME, our two institutions believe that the greatest reach and impact can be achieved in continuing medical education through innovative collaboration. With world-class clinical care protocols and cutting-edge knowledge in both diabetes and cardiac care, we feel that together, we will engage the largest audience more efficiently and effectively.
Why You Should Attend
It is well known that patients with diabetes and the cardiometabolic syndrome are at increased risk for developing cardiovascular disease. With the increase in prevalence of the cardiometabolic syndrome and its comorbidities, the need to optimize preventive and therapeutic interventions is a major focus of most clinicians in primary care. Clinicians must recognize the signs of the cardiometabolic syndrome in order to initiate early and effective preventive interventions to reduce eventual morbidity and mortality.
This summit is for anyone in clinical practice who is providing care for patients with diabetes who are at-risk or have already developed the components of the cardiometabolic syndrome or cardiovascular disease. Experts in diabetes and cardiovascular care from two of the nation's preeminent health care facilities will provide up-to-date reviews of research and clinical trials combined with their cutting-edge perspectives on clinical care.
Topics to be addressed include:
- Pathophysiology of diabetes and the cardiometabolic syndrome
- Controversies in the management of lipids and hypertension
- Cardiac effects of current antidiabetes medications
- Sleep apnea and its relationship to diabetes
- Male testosterone replacement and cardiometabolic risk
- Interventions for coronary disease
- Diabetes and cancer literature analysis
- And more!!
Page last updated: October 10, 2015